Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2012 07:30 ET | Source: BG Medicine, Inc.

BG Medicine Outlines New Commercial Strategy

WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today provided an...
November 13, 2012 07:30 ET | Source: BG Medicine, Inc.

BG Medicine Reports Third Quarter 2012 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today reported financial results for the third quarter ended September 30, 2012 and provided a business...
November 09, 2012 16:45 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. to Present at Lazard Capital Markets 9th Annual Healthcare Conference

WALTHAM, Mass., Nov. 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
November 09, 2012 08:00 ET | Source: BG Medicine, Inc.

BG Medicine Announces Data Analyses Presented at American Heart Association Meeting

WALTHAM, Mass., Nov. 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that...
November 07, 2012 08:09 ET | Source: BG Medicine, Inc.

BG Medicine Announces Decision by American Medical Association and Centers for Medicare and Medicaid Services on Analyte-Specific CPT(R) Code and Reimbursement for BGM Galectin-3(R) Test

WALTHAM, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
November 07, 2012 08:00 ET | Source: BG Medicine, Inc.

BG Medicine to Announce Third Quarter 2012 Earnings Results and Commercial Strategy Update and Host Conference Call on Tuesday, November 13, 2012

WALTHAM, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Tuesday, November 13 at 8:00 a.m. Eastern...
November 05, 2012 08:00 ET | Source: BG Medicine, Inc.

BG Medicine to Highlight Role of Galectin-3 Testing in Reducing Unplanned Hospital Readmissions at the 2012 American Heart Association (AHA) Scientific Sessions

WALTHAM, Mass. and LOS ANGELES, Nov. 5, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today...
October 24, 2012 08:00 ET | Source: BG Medicine, Inc.

BG Medicine Announces Agreement With Kindstar Diagnostics Which Will Provide Galectin-3 Testing Services in China

WALTHAM, Mass., Oct. 24, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
October 18, 2012 08:00 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Appoints Charles H. Abdalian, Jr. as Chief Financial Officer

WALTHAM, Mass., Oct. 18, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
September 11, 2012 08:30 ET | Source: BG Medicine, Inc.

BG Announces Key Additions to Senior Management Team

WALTHAM, Mass., Sept. 11, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...